Extension Study for 2993-112

NCT01789957 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

225

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG: AC2993

Sponsor

AstraZeneca